Introduction
Folate receptor autoantibodies (FRAs) are immune system proteins that mistakenly target folate receptor alpha, a protein located on cell surfaces that facilitates the transport of folate (vitamin B9) into cells. When these autoantibodies interfere with the normal function of folate receptors, they can disrupt the cellular uptake of folate, leading to potential health consequences.
Key Implications of Folate Receptor Autoantibodies
- Interference with Folate Uptake
FRAs can block the proper functioning of folate receptors, reducing the amount of folate that enters cells. This interference can impair critical cellular processes that depend on folate, such as DNA synthesis, repair, and cell division. - Potential Folate Deficiency
The disruption of folate transport caused by FRAs can result in a folate-deficient state. Folate deficiency has been associated with numerous health issues, including:- Anemia (specifically megaloblastic anemia)
- Neurological disorders
- Complications during pregnancy (e.g., neural tube defects)
- Cerebral folate deficiency syndrome (CFDS)
And especially
- Autism spectrum disorders (ASD)
Folate's Importance in Brain Health and Development
Folate is essential for numerous biological functions, particularly during periods of rapid cell growth and division, such as pregnancy and infancy. It plays a critical role in:
-
- DNA synthesis and repair
- Neurotransmitter production (supporting normal brain function)
- Brain health and development
Research has consistently shown (well over a decade now) that a significant number of children with autism spectrum disorder test positive for folate receptor autoantibodies. This suggests that these autoantibodies may hinder the delivery of sufficient folate to the brain, affecting neurological function and development.
Treatment Strategies: Folinic Acid Supplementation
One promising therapeutic approach involves administering folinic acid, an active form of folate. Unlike folic acid—the oxidized form of vitamin B9 commonly found in fortified foods and prenatal supplements—folinic acid does not require enzymatic conversion to become biologically active. This makes it a more direct and readily usable source of folate.
In cases where folate receptor autoantibodies block folate transport through folate receptor alpha, folinic acid can bypass this pathway by utilizing the reduced folate carrier, an alternative transport mechanism.
Supporting Evidence
Numerous studies, including a 2016 double-blind, placebo-controlled study by Frye et al., have demonstrated that children with ASD who tested positive for folate receptor autoantibodies showed significant improvements in communication and language skills when treated with folinic acid. These results were markedly better compared to children without these autoantibodies.
There have been other extensive studies that indicate the same throughout the years. Some of these publications may be found here:
It seems that many children with ASD have been testing positive for folate receptor autoantibodies. And the presence of folate receptor autoantibodies may explain some of their symptoms. Whether it is a cause of autism, or itself a comorbidity, is unknown. Further research remains to be done to elucidate this question. However, treatment with folinic acid in this patient population seems to be quite beneficial.
Just recently, a study out of KK Women’s and Children’s Hospital in Singapore, again, evidenced a large percentage of autistic children with folate receptor autoantibodies and their positive response to folinic acid.
Screening and Diagnosis
Folate receptor autoantibodies can be identified using the FRAT® test. Screening for these autoantibodies is important in individuals experiencing symptoms or conditions linked to folate deficiency, as early detection can guide effective treatment strategies.
Clinical Guidance
As always, any medical intervention, including the use of folinic acid supplements, should be guided by a healthcare professional. Identifying and managing the presence of folate receptor autoantibodies can be crucial for addressing health conditions associated with impaired folate transport. Consult your physician to discuss testing and potential treatments if you suspect folate receptor autoantibodies may be affecting your or your child’s health.
